| Income
[+]
|
in Thousands of Dollars |
|
|
| Operating Revenue |
249 |
309 |
80 |
- |
| Total Revenue |
249 |
309 |
80 |
- |
| Adjustments to Revenue |
N/A |
N/A |
- |
- |
| Cost of Revenue |
2,606 |
3,009 |
642 |
- |
| Cost of Sales With Depreciation |
2,606 |
3,009 |
722 |
- |
| Gross Margin |
(2,358) |
(2,700) |
(561) |
- |
| Gross Operating Profit |
(2,358) |
(2,700) |
(561) |
- |
|
| Selling/General/Admin Expense |
(1,269) |
(553) |
(629) |
(97) |
| Research & Development |
- |
- |
- |
- |
| Advertising |
- |
- |
- |
- |
| EBITDA (Operating Income Before Depreciation) |
- |
- |
(1,191) |
(97) |
| Depreciation & Amortization |
- |
- |
(80) |
- |
| Depreciation, Unreconciled |
- |
- |
- |
- |
| Amortization |
- |
- |
- |
- |
| Amortization of Intangibles |
- |
- |
- |
- |
| Operating Income |
(2,924) |
(1,591) |
(1,271) |
(97) |
| Operating Profit After Depreciation |
(2,924) |
(1,591) |
(1,271) |
(97) |
| Interest Income |
- |
309 |
80 |
- |
| Earnings from Equity Interest |
- |
- |
- |
- |
| Other Income, Net |
2,833 |
(13,093) |
32,192 |
97 |
| Income, Acquired in Process R&D |
- |
- |
- |
- |
| Income, Restructuring and M&A |
- |
- |
- |
- |
| Other Special Charges |
- |
- |
- |
- |
| Total Income Before Interest Expense (EBIT) |
(793) |
- |
31,002 |
- |
| Interest Expense |
N/A |
N/A |
- |
- |
| Income Before Tax |
(793) |
- |
31,002 |
- |
| Income Taxes |
- |
- |
- |
- |
| Minority Interest |
- |
- |
- |
- |
| Preferred Securities of Subsidiary Trust |
- |
- |
- |
- |
| Other Special Charges |
(793) |
- |
- |
- |
| Net Income from Continuing Operations |
(793) |
(16,706) |
31,002 |
- |
| Net Income from Discontinued Operations |
- |
- |
- |
- |
| Net Income from Total Operations |
(793) |
(16,706) |
31,002 |
- |
|
| Normalized Income |
(793) |
(16,706) |
31,002 |
- |
| Extraordinary Income/Loss |
- |
- |
- |
- |
| Special Income/Charges |
- |
- |
- |
- |
| Income from Cum. Effect of Acct Change |
- |
- |
- |
- |
| Income from Tax Loss Carryforward |
- |
- |
- |
- |
| Net Income Available for Common |
(793) |
(16,706) |
31,002 |
- |
| Other Gains |
- |
- |
- |
- |
| Total Net Income |
(793) |
(16,706) |
31,002 |
- |
| Net Income Available for Common |
(793) |
(16,706) |
31,002 |
- |
|
| Results
[+]
|
in Dollars (Preferred Dividends in Thousands) |
|
|
| Dividends Paid Per Share |
1.74 |
1.74 |
0.58 |
0.00 |
| Preferred Dividends |
- |
- |
- |
- |
| Basic EPS from Continuing Operations |
-0.09 |
-1.80 |
3.43 |
0.00 |
| Basic EPS from Discontinued Operations |
0.00 |
0.00 |
0.00 |
0.00 |
| Basic EPS from Extraordinary Income Gains/Losses |
0.00 |
0.00 |
0.00 |
0.00 |
| Basic EPS from Cumulative Effect of Accounting Change |
0.00 |
0.00 |
0.00 |
0.00 |
| Basic EPS from Tax Loss Carryforward |
0.00 |
0.00 |
0.00 |
0.00 |
| Basic EPS from Other Gains/Losses |
0.00 |
0.00 |
0.00 |
0.00 |
| Basic EPS from Total Net Income |
-0.09 |
-1.80 |
3.43 |
0.00 |
| Basic Normalized Net Income per Share |
-0.09 |
-1.80 |
3.43 |
N/A |
| Basic EPS from Total Operations |
-0.09 |
-1.80 |
3.43 |
0.00 |
|
| Diluted EPS from Continuing Operations |
-0.09 |
-1.80 |
3.43 |
0.00 |
| Diluted EPS from Discontinued Operations |
0.00 |
0.00 |
0.00 |
0.00 |
| Diluted EPS from Extraordinary Gains/Losses |
0.00 |
0.00 |
0.00 |
0.00 |
| Diluted EPS from Cumulative Effect of Accounting Change |
0.00 |
0.00 |
0.00 |
0.00 |
| Diluted EPS from Tax Loss Carryforward |
0.00 |
0.00 |
0.00 |
0.00 |
| Diluted EPS from Other Gains/Losses |
0.00 |
0.00 |
0.00 |
0.00 |
| Diluted EPS from Total Net Income |
-0.09 |
-1.80 |
3.43 |
0.00 |
| Diluted Normalized Net Income per Share |
-0.09 |
-1.80 |
3.43 |
N/A |
| Excise Tax |
- |
- |
- |
- |
| Diluted EPS from Total Operations |
-0.09 |
-1.80 |
3.43 |
0.00 |
